Two Sigma Advisers LP reduced its position in Nextgen Healthcare Inc (NASDAQ:NXGN) by 18.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 101,989 shares of the company’s stock after selling 22,447 shares during the period. Two Sigma Advisers LP’s holdings in Nextgen Healthcare were worth $1,545,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also recently added to or reduced their stakes in NXGN. PNC Financial Services Group Inc. lifted its position in Nextgen Healthcare by 37.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 2,387 shares of the company’s stock valued at $36,000 after purchasing an additional 649 shares in the last quarter. Quantamental Technologies LLC bought a new stake in Nextgen Healthcare during the fourth quarter valued at about $60,000. Fox Run Management L.L.C. bought a new stake in Nextgen Healthcare during the fourth quarter valued at about $192,000. BlueMountain Capital Management LLC bought a new stake in Nextgen Healthcare during the third quarter valued at about $205,000. Finally, Quantbot Technologies LP bought a new stake in Nextgen Healthcare during the third quarter valued at about $207,000. Hedge funds and other institutional investors own 71.64% of the company’s stock.
NASDAQ:NXGN opened at $17.77 on Thursday. The company has a current ratio of 1.32, a quick ratio of 1.31 and a debt-to-equity ratio of 0.07. The stock has a market cap of $1.13 billion, a price-to-earnings ratio of 31.18, a price-to-earnings-growth ratio of 2.91 and a beta of 1.15. Nextgen Healthcare Inc has a 52 week low of $13.17 and a 52 week high of $23.73.
A number of equities research analysts have commented on NXGN shares. Zacks Investment Research raised Nextgen Healthcare from a “sell” rating to a “hold” rating in a report on Monday, December 17th. Dougherty & Co raised Nextgen Healthcare from a “neutral” rating to a “buy” rating and set a $19.00 price target on the stock in a report on Friday, January 11th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $18.50.
ILLEGAL ACTIVITY WARNING: “Two Sigma Advisers LP Reduces Stake in Nextgen Healthcare Inc (NXGN)” was originally posted by Markets Daily and is the property of of Markets Daily. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.themarketsdaily.com/2019/04/11/two-sigma-advisers-lp-reduces-stake-in-nextgen-healthcare-inc-nxgn.html.
About Nextgen Healthcare
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Further Reading: How dollar cost averaging works
Want to see what other hedge funds are holding NXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nextgen Healthcare Inc (NASDAQ:NXGN).
Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.